- Title: COVAX says negotiating with new vaccine suppliers, scaling up
- Date: 6th July 2021
- Summary: PUNE, MAHARASHTRA, INDIA (FILE - MAY 18, 2020) (REUTERS) SIGN READING (English): "SERUM INSTITUTE OF INDIA PVT.LTD."
- Embargoed: 20th July 2021 15:15
- Keywords: COVAX Covid-19 WHO vaccines
- Location: ABIDJAN, IVORY COAST / GENEVA, SWITZERLAND / PUNE, MAHARASHTRA, INDIA / ACCRA, GHANA / ADDIS ABABA, ETHIOPIA / BRUSSELS, BELGIUM / SAN LUIS TALPA, EL SALVADOR / CHOLOMA, HONDURAS
- City: ABIDJAN, IVORY COAST / GENEVA, SWITZERLAND / PUNE, MAHARASHTRA, INDIA / ACCRA, GHANA / ADDIS ABABA, ETHIOPIA / BRUSSELS, BELGIUM / SAN LUIS TALPA, EL SALVADOR / CHOLOMA, HONDURAS
- Country: Switzerland
- Topics: Europe,Health/Medicine
- Reuters ID: LVA006EKPF5TZ
- Aspect Ratio: 16:9
- Story Text: The COVAX dose-sharing facility expects to have 1.9 billion doses of COVID-19 vaccines available by year-end, including 1.5 billion earmarked for the poorest countries, its managing director Aurelia Nguyen said on Tuesday (July 6).
The GAVI vaccine alliance, which runs COVAX with the World Health Organization, expects a "very strong increase in COVID-19 vaccine availability" towards the fourth quarter, she said.
COVAX, which has distributed some 95 million doses to 134 countries since late February, is diversifying its portfolio and is negotiating with new suppliers, she said.
Tedros Adhanom Ghebreyesus, the head of the World Health Organization (WHO), said that the world is facing a "two-track pandemic" with some countries being hit by waves of hospitalization and deaths, compounded by coronavirus variants,
John Ryan, a senior European Commission health official, told a briefing that the bloc hoped to donate a further 100 million doses of COVID-19 vaccines to low- and middle-income countries by year-end, using the COVAX facility as the main channel.
(Production: Cecile Mantovani) - Copyright Holder: FILE REUTERS (CAN SELL)
- Copyright Notice: (c) Copyright Thomson Reuters 2021. Open For Restrictions - http://about.reuters.com/fulllegal.asp
- Usage Terms/Restrictions: None